MedTrace Logo

Evaluating Nine-Year Sustainability After Implementing Evidence-Based Practices to Prevent Urinary Tract Infections and Overfilling of the Bladder in Patients With Hip Fracture

NCT06893562 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 750

Last updated 2026-03-25

No results posted yet for this study

Summary

This study focuses on evaluating the long-term sustainability of a urinary catheter care bundle designed to prevent urinary tract infections and bladder distension in patients undergoing surgery for hip fractures. The intervention, which included two key innovations-a urinary catheter certificate and a nurse-driven urinary catheter protocol, was implemented between 2015 and 2020 and successfully reduced urinary tract infections and bladder distension, previously published. However, due to the pandemic, the initiative was paused and had to be reintroduced in 2022. Now, the study aims to assess the effectiveness of these preventive measures 9 years after their initial implementation. The research will analyze changes in the incidence of urinary tract infections, bladder distension, catheterisation methods, and documentation practices in patients aged 65 and older. The findings will help inform healthcare policies and may have broader implications for preventing adverse events in other surgical patient groups

Conditions

  • Urinary Catheters
  • Urinary Retention
  • Adherence
  • Documentation Skill
  • Sustainability of Innovations
  • Hip Fracture
  • UTI - Urinary Tract Infection

Interventions

BEHAVIORAL

Safe Hands and Safe Bladder intervention

Evaluating changes in urinary tract infections and bladder distension nine-year after implementing preventive measures

Sponsors & Collaborators

  • Sahlgrenska University Hospital

    lead OTHER

Principal Investigators

  • Annette Erichsen, Associate Professor · Gothenburg University, Sahlgrenska University Hospital

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-05-05
Primary Completion
2025-10-30
Completion
2025-10-30

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06893562 on ClinicalTrials.gov